Publicaciones en las que colabora con Victoria Beatriz Lerma Hambleton (6)

2021

  1. Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study

    BMC Medicine, Vol. 19, Núm. 1

2020

  1. Assessment of drug causality in Stevens-Johnson syndrome/toxic epidermal necrolysis: Concordance between lymphocyte transformation test and ALDEN

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

    The Lancet, Vol. 395, Núm. 10238, pp. 1705-1714

2019

  1. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 237-246

2018

  1. Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database

    Pharmacoepidemiology and Drug Safety, Vol. 27, Núm. 9, pp. 1042-1050

2017

  1. Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches

    Journal of Investigative Dermatology, Vol. 137, Núm. 10, pp. 2092-2100